This inventor holds 1 USPTO granted patent. Top assignee: Argenx Bv. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Patrick Dupuy: Innovator in Pemphigus Treatment
Introduction
Patrick Dupuy is a notable inventor based in Zwijnaarde, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of pemphigus disorders. His innovative approach has led to the development of effective methods that enhance patient care.
Latest Patents
Patrick Dupuy holds a patent for "Methods for treating pemphigus disorders." This patent outlines methods for treating pemphigus using an FcRn antagonist such as efgartigimod. The invention provides a rapid onset of action, enabling early disease control and maintenance of clinical remission, with or without a minimal dose of corticosteroids. He has 1 patent to his name.
Career Highlights
Patrick Dupuy is associated with Argenx BV, a company known for its focus on innovative therapies for severe autoimmune diseases. His work at Argenx has been pivotal in advancing treatment options for patients suffering from pemphigus.
Collaborations
One of his notable coworkers is Peter Verheesen, with whom he has collaborated on various projects aimed at improving treatment methodologies.
Conclusion
Patrick Dupuy's contributions to the field of pemphigus treatment exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective therapies for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile